Relationship Between Remnant Cholesterol and Risk of Heart Failure in a Community Population Without Cardiovascular Disease: Results of the China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project

残余胆固醇与无心血管疾病社区人群心力衰竭风险的关系:中国以患者为中心的百万人心脏事件评估项目结果

阅读:1

Abstract

BACKGROUND: The association between heart failure (HF) and remnant cholesterol (RC) has not been comprehensively elucidated. METHODS: This study assessed data from 90 280 individuals (mean age, 54 years; 61.2% women) in the China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project, all free of cardiovascular disease at baseline. RC was calculated by the equation: total cholesterol minus high-density lipoprotein cholesterol minus low-density lipoprotein cholesterol (LDL-C), with low-density lipoprotein cholesterol derived using the Friedewald equation. Cox proportional hazards model was used to examine the relationship of RC to HF risk. We also assessed the correlation between left ventricular structure and function and RC levels using multivariable linear regression models in 15 004 participants with echocardiographic data. RESULTS: The study had a median follow-up period of 3.52 years and recorded 1105 new-onset HF events. In multivariable models, every SD increment in RC was associated with a 7% increased risk of HF (hazard ratio [HR], 1.07 [95% CI, 1.01-1.13]), with a noted gradient of association. Even after accounting for interim myocardial infarction/coronary heart disease, individuals with high baseline RC (≥1.1 mmol/L) remained at a 24% greater HF risk (HR, 1.24 [95% CI, 1.05-1.46]) than the low group (<0.63 mmol/L). Each SD in the log-transformed baseline RC increase was significantly correlated with increases in relative wall thickness (β=0.0014; P=0.01) and left ventricular mass index (β=0.45; P=0.01). CONCLUSIONS: Elevated RC is linked to unfavorable left ventricular structure and function alterations, increasing the risk of subsequent HF. This association with HF appears to be independent of interim myocardial infarction/coronary heart disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。